Literature DB >> 8679226

Inhibition of the transcription factors NF-kappa B and AP-1 underlies loss of cytokine gene expression in rat alveolar macrophages treated with a diffusible product from the spores of Aspergillus fumigatus.

W J Nicholson1, J Slight, K Donaldson.   

Abstract

The spores of Aspergillus fumigatus have a survival advantage over other respirable fungal spores in the lung, leading to a number of lung diseases associated with this fungus. We have hypothesized that a component on the spore surface can inhibit the activation of alveolar macrophages, known to play an essential role in immune regulation in the lung. A diffusible product from the spores of A. fumigatus (AfD) inhibited the production of tumor necrosis factor alpha (TNF alpha) protein by alveolar macrophages in an enzyme-linked immunosorbent assay. Using a semiquantitative reverse transcription-polymerase chain reaction, we also demonstrated a potent inhibitory effect of AfD on the production of proinflammatory cytokine transcripts in rat alveolar macrophages. The inhibition occurred at the level of transcription, with AfD inhibiting the synthesis of TNF alpha-and interleukin 6 (IL-6)-specific mRNA transcripts. No effect was seen on the synthesis of interleukin 1 beta (IL-1 beta) cytokine transcripts or on the expression of the housekeeping gene beta-actin. Furthermore, AfD specifically inhibited the activation of nuclear transcription factors NF-kappa B and AP-1, both of which are required for the coordinate upregulation of transcription of the proinflammatory cytokines TNF alpha, IL-1 beta, and IL-6. We conclude that AfD can inhibit normal alveolar macrophage responses by selectively inhibiting the production of key inflammatory cytokines, and that the mechanism of inhibition is primarily at the level of transcriptional activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8679226     DOI: 10.1165/ajrcmb.15.1.8679226

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  16 in total

1.  Effects of Aspergillus fumigatus culture filtrate on antifungal activity of human phagocytes in vitro.

Authors:  T Murayama; R Amitani; Y Ikegami; R Kawanami; W J Lee; R Nawada
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung.

Authors:  Robert Foronjy; Jeanine D'Armiento
Journal:  Clin Appl Immunol Rev       Date:  2006-01-01

Review 3.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

4.  Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung.

Authors:  I M Bromley; K Donaldson
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

5.  Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.

Authors:  Michael B Fessler; Patrick G Arndt; Ingo Just; Jerry A Nick; Kenneth C Malcolm; G Scott Worthen
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

6.  Enhanced binding of Aspergillus fumigatus spores to A549 epithelial cells and extracellular matrix proteins by a component from the spore surface and inhibition by rat lung lavage fluid.

Authors:  Z Yang; S M Jaeckisch; C G Mitchell
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

7.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

8.  Diffusible component from the spore surface of the fungus Aspergillus fumigatus which inhibits the macrophage oxidative burst is distinct from gliotoxin and other hyphal toxins.

Authors:  C G Mitchell; J Slight; K Donaldson
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

Review 9.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

10.  Activator protein-1 activation in acute lung injury.

Authors:  Ren-Feng Guo; Alex B Lentsch; J Vidya Sarma; Lei Sun; Niels C Riedemann; Shannon D McClintock; Stephanie R McGuire; Nico Van Rooijen; Peter A Ward
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.